@article{article, title  = {{Improved tumor response and survival outcomes with post-transplant bortezomib (Btz) consolidation versus observation (Obs) alone in patients with newly diagnosed multiple myeloma (MM): Results from a randomized, open-label, multicenter, parallel-group phase 2 study}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2015}},

 month = {{9}},

 author = {{Sezer O and Terpos E and Hajek R and Sucak G and Cagirgan S and Linkesch W and Akay OM and Armbrecht G and Plesner T and Snowden JA and Nahi H et al}},

 doi = {{10.1016/j.clml.2015.07.323}},

 volume = {{15}},

 journal = {{Clinical Lymphoma Myeloma and Leukemia}},

 pages = {{e129-e130}},

 note = {{Accessed on 2024/12/22}}}